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ELECTROPHYSIOLOCIC EFFECTS OF LEFT VENTRICULAR HYPER- 
TROPHY IN VIVO: EFFECT OF PRARMACOLOCIC INTERVENTION. 
Peter R. Kowey, M.D., F.A.C.C. k Ted D. Friehling, M.D., 
F.A.C.C., Joseph Sewter, B.S., Wu Ying, M.D., James 
Paul, R.V.C.P., Alexis Sokil, M.D., F.A.C.C.. Medical 
College of Pennsylvania, Philadelphia, PA. 
In order to define the arrhythmogenic effects of left 
ventricular hypertrophy (LVR) in the intact heart, we 
out a detailad alectrophysiologic asersrment in 
viously validated feline aort 
ntricular conduceion timee, UI 
ity thresholds (ET), ventricular ref 
(VRP d mean monophaaic act ion po 
brillation occurring 
either rpontaneouely, or induced with programmed eeimula- 
tion. Cmpored to the ehom control 
had a greeter dirpereion of VRP (3 
mrec; p<O.OOl), and MAPDg 
P< 1. Verapamil (0.30 then infusion of 10 
mc /min) hod no tignif ece on these electro- 
physiologic properties, nor did it affect VP thresholds 
or indusibility by programmed stimulation. However, 
Rieotilide (5 r&kg) an inhibitor of the voltage- 
dependent poetassium channel narrowed dispersion of VRP 
and EAPD concomitant wieh a marked reduction in ventricu- 
lar vulnerability. Thuss LVH has a pronounced ef feet on 
dispersion of refractoriness and repolarization. 
Blockade of the voltage-dependent potassium channel, but 
not the slow calcium channel, narrows the dispersion of 
recovery of excitability and protects against ventricu- 
lar fibrillation. 
The New Calcium Channel Blocker Ro-236 
Prev ents Reperfus ion Arrhythmias in Dogs. 
152 (Roche) 
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Ooes increased cardiac Ca2+ current play a role In the 
genesis of reperfusion arrhythmias? This was tested in 
n ke instrumented dog model of coronary occlusion 
ue spontaneous In vlvothrombus formation in the 
circumflex artery mcurrent application. LCX 
blood flow by Doppler, EC6, myocardial contractility by 
length-segment crystals, and coronary sinus 
noreplnephrine release (&K) were measured through out 
the study. After 45 min of occlusion (no LCX blood 
flow, marked ST elevation, marked impairment in 
posterior wall contractility, and more than 2 fold 
increase in coronary sinus NE)* reperfusion was 
established with lo6 units of streptokinase and 5000 
units of heparln IV. Just prior to thrombolysis, 
control dogs received the vehicle (normal saline) and 
experimental group received 0.3mg/kg of RO-236152 IV 
(napthothiazepinone type Ca2* channel blocker, Roche) 
followed by a 30ug/kg/min infusion for 60 min. 
The incidence of ventricular ectopy including 
tachycardia < 7 beats long (VPB) or tachycardia (VT) or 
fibrillation (VF) was: 
Type VPB 
Control (n=lB) O/18 1:x8 6::B 
15/20* 4/20** 1/20+ 
In this model, 
*p<O.OOS, compared to controls 
reperfusion-induced ventricular 
arrhythmias a d fibrillation may be partially mediated 
by cardiac B+ Ca current. 
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